FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $4.31, $0.58 better than the analyst estimate of $3.73. Revenue for the quarter came in at $2.79 billion versus the consensus estimate of $2.73 billion.
GUIDANCE:
Quest Diagnostics sees FY2020 EPS of $9.00-$10.00, versus the consensus of... More

